Work

Advances in the pathogenesis of hidradenitis suppurativa: new therapeutic targets and emerging treatments

Year: 2025
Type: dissertation
Abstract: Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the pilosebaceous unit, characterized by the formation of painful nodules, abscesses and fistulous tracts in the intertriginous areas that severely impact patients' quality of life. This paper systematically reviews the scientific literature on advances in understanding the pathogenesis of HS, as well as the development of emerging treatments for controlling the disease in its severe forms. The central role of cytokines in the pathogenesis of HS is analyzed, highlighting the roles of TNF-α and IL-1β, IL-36, and IL-17, as well as the involvement of other agents such as adipokines, the complement system, and neutrophils. Understanding these pathogenetic mechanisms has allowed the development of targeted therapies, such as the biologic drugs currently approved for severe HS (adalimumab, secukinumab, bimekizumab), which have demonstrated efficacy in both clinical trials and real-world clinical practice. However, a percentage of patients do not respond adequately to these treatments. Therefore, highly promising new therapeutic options are being investigated, such as anti-IL-1, anti-IL-36, new anti-IL-17, and JAK inhibitors, which may offer better results in disease control.
Author: Santiago Setién, Ángel
Language: Spanish
Subfield: Dermatology
Field: Medicine
Open Access status: green
OpenAlex ID: W7110643541
Cites:
Cited by:
Related to: 10